Your Search Results

Best companions's case on complications in calcified lesions: episode 2

22 May 2025 – From EuroPCR 2025

Join this session examining complex complications in calcified lesion interventions. Learn from cases featuring controversial approaches that successfully resolved issues, coronary perforation management, retrograde iatrogenic dissection after lithotripsy, and algorithmic bailout strategies essential for navigating challenging calcified lesion complications.

Best companions's case on complications in calcified lesions: episode 2

Coronary complications: perforation and dissection

22 May 2025 – From EuroPCR 2025

Examine the unpredictable nature of coronary complications such as perforation and dissection during PCI. This session presents real-world cases illustrating sequential complications, their management challenges, and strategies to simplify complex scenarios. Understand how to anticipate, recognize, and effectively respond to these critical incidents to improve procedural...

Coronary complications: perforation and dissection

Acute complications during distal left main PCI - Part 2

22 May 2025 – From EuroPCR 2025

This session focuses on acute complications encountered during distal left main PCI. Review real-world challenging cases involving multiple unexpected complications, device retrieval techniques, fractured rota burr management during rota-tripsy, and strategies to navigate complex procedural challenges.

Acute complications during distal left main PCI - Part 2

Managing TAVI-embolisation device

22 May 2025 – From EuroPCR 2025

Focus on managing TAVI device embolization in this specialized session. Discuss detailed techniques such as TAVI-in-TAVI procedures, addressing valve dysfunction, and innovative balloon-assisted retrieval methods for migrated transcatheter heart valves, emphasizing procedural nuances and bailout strategies.

DCB in in-stent restenosis - LIVE Case

07 Apr 2026 – From GulfPCR-GIM 2025

A 60-year-old male with hypertension, type II diabetes, and moderately impaired LV function (45%), has a history of LAD PCI treated with three Cypher stents in 2006. He underwent further treatment for LAD in-stent restenosis in 2012, 2020, and 2022 using a new stent and DCB....

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author

Alessandro Sticchi

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes across key global studies presented at TCT 2025

29 Oct 2025

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...